Alcon (Ciba Vision)

Established in 1993, Alcon Korea is a pharmaceutical wholesaler, including pharmaceuticals, medical devices, and contact lenses. It provides a total solution related to the eyes, including various eye drops, intraocular lenses, ophthalmic surgery equipment, and contact lens care products. As a global leading company in the field of ophthalmology that operates the surgical and vision care divisions, it distributes professional surgical equipment related to cataract, glaucoma, retina, and LASIK surgery, such as Acrysopr monofocal/multifocal intraocular lens and femtosecond laser. In addition, it has a wide range of product lineups including dry eye products such as Kynix and contact lenses and lens care such as Water Lens Daily Total One.

Alcon Korea is well known for its storage solution called 'Opti-Free'. Optifree is a multi-purpose lens care solution for various lens wearers, such as soft lenses and silicone hydrogel lenses. Alcon's first tear-activating complex, 'Tearglide', is used to condition the lens in two stages: when storing the lens and when wearing the lens. It has the advantage of keeping the lens moist and comfortable to wear for 14 hours. In addition, Air Lens, a major product of Alcon, is a contact lens made of silicone hydrogel, and has a significantly higher oxygen transmission rate than normal contact lenses, so that moisture is maintained. In particular, as a contact lens worn for a short period of time, it is characterized by being comfortable and not having to be removed for a whole month, which is rare, and has gained much popularity.

In May 2022, a nationwide road show was launched to commemorate the launch of the new intraocular lens platform 'Clareon'. Clareon is an intraocular lens necessary for multifocal intraocular lens surgery and presbyopia correction surgery, reducing night light blur and improving night vision. Ophthalmologists can secure long-term stability in ophthalmologic surgery through Clareon, which supplements the disadvantages of the existing Acrysoft technology and maintains the advantages. Furthermore, more treatment options for cataracts can be provided to patients.